-
Founded in:
2003-02-08 -
Country:
China -
Address:
No. 28, Hengjing Road, Nanjing Economic and Technological Development Zone -
Tax NO.:
91320192745372941T -
Registered Funds:
66 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Reboxetine mesylate |
Extract from the above information
More
Extract from the above information |
71620-89-8 | 3 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lansoprazole |
Inhibit gastric acid secretion and is used to treat gastric ulcer, duodenal ulcer, reflux esophagitis and other diseases
More
Inhibit gastric acid secretion and is used to treat gastric ulcer, duodenal ulcer, reflux esophagitis and other diseases |
103577-45-3 | 88 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Foscarnet sodium |
Unspecified
More
Unspecified |
63585-09-1 | 19 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Moxifloxacin hydrochloride |
|
186826-86-8 | 89 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clotrimazole |
(1) Inhibit plasminogen activators, preventing plasminogen from activating into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect. (2) Promote the release of active substances from platelets, enhance platelet aggregation and adhesion, shorten coagulation time, and produce a hemostatic effect. (3) Enhance capillary resistance and reduce capillary permeability, thereby reducing bleeding.
More
(1) Inhibit plasminogen activators, preventing plasminogen from activating into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect. (2) Promote the release of active substances from platelets, enhance platelet aggregation and adhesion, shorten coagulation time, and produce a hemostatic effect. (3) Enhance capillary resistance and reduce capillary permeability, thereby reducing bleeding. |
0 |